Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › ENSC Leadership & Pay · Jul 15, 2026
On July 10, 2026, Jeffrey Millard resigned from his position as Chief Operating Officer of Ensysce Biosciences, Inc.… ENSC Ensysce Biosciences, Inc.
On July 10, 2026, Jeffrey Millard resigned from his position as Chief Operating Officer of Ensysce Biosciences, Inc., effective immediately. The company operates in the biotechnology industry, focusing on the development of non-opioid pain therapies.
More from Ensysce Biosciences, Inc. All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
